Biotech is rewriting the rules of healthcare. CRISPR gene editing is curing genetic diseases once thought untreatable. mRNA technology, proven during the COVID-19 pandemic, is now being used for cancer vaccines. Startups are racing to develop personalized therapies based on genetic profiles. AI is accelerating drug discovery, cutting years off development timelines. Biotech IPOs are surging, attracting investors hungry for innovation. Regulatory bodies are adapting fast, approving treatments at record speeds. Ethical debates are heating up, especially around human enhancement. The biotech boom isn’t just about curing illness—it’s about redefining what it means to be human.